Literature DB >> 28231720

Tumor-associated macrophages: implications in cancer immunotherapy.

Amy J Petty1, Yiping Yang1,2.   

Abstract

Tumor-associated macrophages (TAMs), representing most of the leukocyte population in solid tumors, demonstrate great phenotypic heterogeneity and diverse functional capabilities under the influence of the local tumor microenvironment. These anti-inflammatory and protumorigenic macrophages modulate the local microenvironment to facilitate tumor growth and metastasis. In this review, we examine the origin of TAMs and the complex regulatory networks within the tumor microenvironment that facilitate the polarization of TAMs toward a protumoral phenotype. More extensively, we evaluate the mechanisms by which TAMs mediate angiogenesis, metastasis, chemotherapeutic resistance and immune evasion. Lastly, we will highlight novel interventional strategies targeting TAMs in preclinical studies and in early clinical trials that have significant potential in improving efficacy of current chemotherapeutic and/or immunotherapeutic approaches.

Entities:  

Keywords:  immunotherapy; tumor microenvironment; tumor-associated macrophages (TAM)

Mesh:

Year:  2017        PMID: 28231720      PMCID: PMC5619052          DOI: 10.2217/imt-2016-0135

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  98 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

2.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

Authors:  Subhra K Biswas; Lisa Gangi; Saki Paul; Tiziana Schioppa; Alessandra Saccani; Marina Sironi; Barbara Bottazzi; Andrea Doni; Bronte Vincenzo; Fabio Pasqualini; Luca Vago; Manuela Nebuloni; Alberto Mantovani; Antonio Sica
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

Review 3.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

4.  Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

Authors:  Manisha Singh; Hiep Khong; Zhimin Dai; Xue-Fei Huang; Jennifer A Wargo; Zachary A Cooper; John P Vasilakos; Patrick Hwu; Willem W Overwijk
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

5.  The origin and function of tumor-associated macrophages.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2014-09-15       Impact factor: 11.530

6.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Babak Baban; Heather P Harding; Yuhong Zhang; David Ron; Andrew L Mellor
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

7.  Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment.

Authors:  Alexander M Lesokhin; Tobias M Hohl; Shigehisa Kitano; Czrina Cortez; Daniel Hirschhorn-Cymerman; Francesca Avogadri; Gabrielle A Rizzuto; John J Lazarus; Eric G Pamer; Alan N Houghton; Taha Merghoub; Jedd D Wolchok
Journal:  Cancer Res       Date:  2011-12-15       Impact factor: 12.701

8.  Adaptive immunity maintains occult cancer in an equilibrium state.

Authors:  Catherine M Koebel; William Vermi; Jeremy B Swann; Nadeen Zerafa; Scott J Rodig; Lloyd J Old; Mark J Smyth; Robert D Schreiber
Journal:  Nature       Date:  2007-11-18       Impact factor: 49.962

9.  Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer.

Authors:  Mengmeng Niu; Solange Valdes; Youssef W Naguib; Stephen D Hursting; Zhengrong Cui
Journal:  Mol Pharm       Date:  2016-04-26       Impact factor: 4.939

10.  CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells.

Authors:  Debbie C Strachan; Brian Ruffell; Yoko Oei; Mina J Bissell; Lisa M Coussens; Nancy Pryer; Dylan Daniel
Journal:  Oncoimmunology       Date:  2013-12-04       Impact factor: 8.110

View more
  104 in total

Review 1.  IFN-γ: A cytokine at the right time, is in the right place.

Authors:  J Daniel Burke; Howard A Young
Journal:  Semin Immunol       Date:  2019-06-17       Impact factor: 11.130

2.  Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.

Authors:  Cong-Cong Wu; Hao Li; Yao Xiao; Lei-Lei Yang; Lei Chen; Wei-Wei Deng; Lei Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  J Mol Histol       Date:  2018-05-30       Impact factor: 2.611

Review 3.  Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy.

Authors:  Meng Lan; Wenping Lu; Tengteng Zou; Lihong Li; Fengjie Liu; Tiange Cai; Yu Cai
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

4.  Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression.

Authors:  Ye Bi; Venktesh S Shirure; Ruiyang Liu; Cassandra Cunningham; Li Ding; J Mark Meacham; S Peter Goedegebuure; Steven C George; Ryan C Fields
Journal:  Integr Biol (Camb)       Date:  2020-09-30       Impact factor: 2.192

Review 5.  A bite to fight: front-line innate immune defenses against malaria parasites.

Authors:  Stephanie Tannous; Esther Ghanem
Journal:  Pathog Glob Health       Date:  2018-01-29       Impact factor: 2.894

6.  Tumor-Associated T-Lymphocytes and Macrophages are Decreased in Endometrioid Endometrial Carcinoma with MELF-Pattern Stromal Changes.

Authors:  Dmitry Aleksandrovich Zinovkin; Md Zahidul Islam Pranjol; Il'ya Andreevich Bilsky; Valeriya Alexandrovna Zmushko
Journal:  Cancer Microenviron       Date:  2018-07-14

7.  Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab.

Authors:  Emily Z Keung; Melissa Burgess; Ruth Salazar; Edwin R Parra; Jaime Rodrigues-Canales; Vanessa Bolejack; Brian A Van Tine; Scott M Schuetze; Steven Attia; Richard F Riedel; James Hu; Scott H Okuno; Dennis A Priebat; Sujana Movva; Lara E Davis; Damon R Reed; Alexandre Reuben; Christina L Roland; Denise Reinke; Alexander J Lazar; Wei-Lien Wang; Jennifer A Wargo; Hussein A Tawbi
Journal:  Clin Cancer Res       Date:  2020-01-03       Impact factor: 12.531

8.  Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages.

Authors:  Pan Su; Qiang Wang; Enguang Bi; Xingzhe Ma; Lintao Liu; Maojie Yang; Jianfei Qian; Qing Yi
Journal:  Cancer Res       Date:  2020-02-03       Impact factor: 12.701

9.  Key Candidate Genes - VSIG2 of Colon Cancer Identified by Weighted Gene Co-Expression Network Analysis.

Authors:  Zhongze Cui; Yangyang Li; Shuang He; Feifei Wen; Xiaoyang Xu; Lizhen Lu; Shuhua Wu
Journal:  Cancer Manag Res       Date:  2021-07-15       Impact factor: 3.989

Review 10.  Immunology and Immunotherapeutic Approaches for Advanced Renal Cell Carcinoma: A Comprehensive Review.

Authors:  Yoon-Soo Hah; Kyo-Chul Koo
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.